Clusters of imprinted genes are often controlled by an imprinting center that is necessary for allele-specific gene expression and to reprogram parent-of-origin information between generations. An imprinted domain at 15q11-q13 is responsible for both Angelman syndrome (AS) and Prader-Willi syndrome (PWS), two clinically distinct neurodevelopmental disorders. Angelman syndrome arises from the lack of maternal contribution from the locus, whereas Prader-Willi syndrome results from the absence of paternally expressed genes. In some rare cases of PWS and AS, small deletions may lead to incorrect parent-of-origin allele identity. DNA sequences common to these deletions define a bipartite imprinting center for the AS-PWS locus. The PWS-smallest region of deletion overlap (SRO) element of the imprinting center activates expression of genes from the paternal allele. The AS-SRO element generates maternal allele identity by epigenetically inactivating the PWS-SRO in oocytes so that paternal genes are silenced on the future maternal allele. Here we have investigated functional activities of the AS-SRO, the element necessary for maternal allele identity. We find that, in humans, the AS-SRO is an oocyte-specific promoter that generates transcripts that transit the PWS-SRO. Similar upstream promoters were detected in bovine oocytes. This result is consistent with a model in which imprinting centers become DNA methylated and acquire maternal allele identity in oocytes in response to transiting transcription.
Angelman syndrome | imprinting | oocytes T he process of genetic imprinting results in the selective silencing of one parent's alleles. Imprinted genes are often clustered and have an imprinting center (IC) that regulates both allele-specific gene expression and the resetting of parental allele identity between generations. The imprinted domain at 15q11-15q13 is unusual not only in that it contains both maternally and paternally imprinted genes, but also in that it underlies two clinically distinct syndromes. Angelman syndrome (AS) [Mendelian Inheritance in Man (MIM) 105830] results from the absence of a functional UBE3A gene product transcribed from the maternal allele (1, 2) . Several genes are expressed only from the paternal allele at this locus, and mutations in two of these genes are currently implicated in traits associated with Prader-Willi syndrome (PWS) (MIM 17620) (3, 4) . Most individuals with either AS or PWS harbor a 5-to 7-Mb deletion spanning the entire imprinted domain, but some cases of AS or PWS are the result of a failure to reset parent-of-origin allele identity between generations. These AS and PWS imprinting defects may be accompanied by much smaller deletions of sequences essential to the imprint resetting process. The smallest regions of overlap common to these deletions indicate sequences necessary for allele identity and thereby define the AS-PWS imprinting center. Thus, the IC at the PWS-AS locus is defined by genetic lesions detected in individuals with AS or PWS imprinting defects, rather than by engineered mutations in mice as has been used at most imprinted domains (5). The PWS-AS imprinting center is also atypical in that it consists of two separate DNA elements. The 4.3-kb PWS-smallest region of deletion overlap (SRO) spans the SNURF/SNRPN (henceforth SNRPN) major promoter and exon 1. This element is required for paternal expression of genes implicated in PWS (6) . The 880-bp AS-SRO is located ∼35 kb centromeric and upstream of the PWS-SRO. This element is deleted in some individuals with AS imprinting defects and is required for silencing of PWS genes on the maternal chromosome and subsequent expression of UBE3A (7).
Here we will use the terms AS-SRO and PWS-SRO to refer to the sequences deleted in individuals with AS and PWS imprinting defects and use AS-IC and PWS-IC to refer to the imprinting activities of these elements. The prevailing model of the roles of these two elements posits that the PWS-IC functions somatically to activate paternal allele transcription. The PWS-IC activates several protein-encoding genes including MKRN3, MAGEL2, NECDIN, and SNRPN. The SNRPN gene is part of complex transcript that is also host to several small nucleolar RNAs and to UBE3A-ATS. UBE3A-ATS is transcribed in antisense direction to UBE3A and silences the paternal UBE3A allele, potentially by a transcriptional collision mechanism (8) . The AS-IC functions in female germ cells to epigenetically inactivate the PWS-IC and thereby silence paternally expressed genes on the future maternal allele (9) . The absence of maternal UBE3A-ATS transcription on the maternal allele is necessary for UBE3A expression and the avoidance of AS.
Targeted mutations in mice confirm that the PWS-IC functions somatically, activates paternal gene expression, and is necessary to silence the paternal Ube3a allele (10) (11) (12) (13) (14) . However, the absence of a conserved AS-SRO sequence in mice has stymied functional investigations into this element of the imprinting center. Horsthemke and colleagues were, to our knowledge, the first to suggest that the AS-IC uses transcription to inactivate the PWS-IC (15) . These investigators noted that the SNRPN transcription unit contains several upstream (U) exons located over 130 kb that splice into SNRPN exon 2, thereby replacing exon 1. Two of these U exons are located within the 880-bp AS-SRO (15) (16) (17) . Extrapolating from these paternally derived transcripts detected in brain tissue, they speculated the existence of similar transcripts in oocytes that would transit the PWS-SRO and thereby contribute to the imprint-setting process. Although lacking sequence homology, the mouse Snrpn locus also contains several upstream promoter exons that are alternatives to body exon 1 (10, 18) . These transcripts become detectable in mouse oocytes just before the application of DNA methylation at the PWS-IC (19, 20) . Using BAC transgenes containing both mouse Snrpn upstream and body exons, we recently demonstrated that these oocyte transcripts transiting the PWS-IC are necessary and sufficient to observe both DNA methylation at the PWS-IC and imprinted Snrpn expression (20) . These results suggest that imprint setting at the PWS-AS locus is part of a generalized oocyte mechanism in which transcribed CpG islands become methylated (21, 22) .
Although transcription transiting the human PWS-SRO is likely essential to imprint-setting activity, the molecular functions of the human AS-SRO remain unclear. We have now investigated potential activities of the AS-SRO in human oocytes. In contrast to the patterns observed in brain, we find that few oocyte SNRPN transcripts initiate at the major promoter at exon 1. Instead, the AS-SRO is a frequent start site for oocyte SNRPN transcripts. Upstream initiation likely ensures that transcripts cross the complete PWS-SRO and contribute to setting the maternal imprint.
Results
Previously Unidentified SNRPN Transcripts in Human Oocytes. The SNRPN transcription unit has a complex pattern of transcription initiation and processing in somatic tissues. The University of California at Santa Cruz (UCSC) Genome Browser and Fig. 1 demonstrate that somatic SNRPN transcripts most commonly initiate at exon 1, and nearly all remaining transcripts have 5′ ends at either exon U1B or U1A, located 130 and 100 kb upstream, respectively (23) . Transcripts initiated at U1A or U1B may also include one or more internal upstream exons, numbered U2-U8 distally to proximally, before splicing into SNRPN body exon 2. These primary transcripts thus transit across the entire PWS-SRO (17) . Previous work indicates that imprint setting on the maternal allele at the mouse PWS-AS locus is dependent on Snrpn transcripts transiting the PWS-IC in mouse oocytes (20) . To better understand the role that transcription plays in imprint setting at the human PWS-AS locus, we applied 5′ rapid amplification of cDNA ends (5′ RACE) to human oocyte RNA. To ensure that our results would not be limited to a rare pattern unique to one oocyte or a single donor, we characterized RNA obtained from pools composed of six oocytes retrieved from at least three donors. A primer located in SNRPN body exon 3 was used to initiate cDNA synthesis, and a second reverse primer in SNRPN exon 2 was used for PCR amplification before cloning. 5′ RACE detected five previously undocumented SNRPN transcription start sites in oocytes, all within or near the AS-SRO, the smallest region of overlapping deletions present in some individuals with imprinting defects (Fig. 1B) . Most RACE clone 5′ ends fell within the 880-bp AS-SRO, but several were located just 40 bp downstream of the proximal boundary of the AS-SRO in a previously unidentified exon named "U6.5." In brain and testis, the rare transcripts may have 5′ ends even further upstream than UIB (17), but RACE using reverse primers in U2 failed to detect additional upstream 5′ ends in oocytes.
We were surprised by the absence of SNRPN exon 1-derived transcripts among the oocyte RACE products. To confirm these findings, we performed RT-PCR using forward primers in previously known or in newly discovered exonic sequence paired with a reverse primer in SNRPN body exon 3. The products were then Southern blotted using a probe containing body exon 2 to identify transcripts that had transited across the PWS-SRO. Fig. 1C corroborate the 5′ RACE results and show that exon 1 is rarely used in human oocytes. This is in stark contrast to its use in the brain as the major promoter. These results also illustrate the nearly reciprocal patterns of SNRPN transcription initiation in brain and oocytes. Although the AS-SRO is largely unused in brain, it is a focal point for transcription initiation in oocytes.
Results in
Also notable is the absence of transcripts that initiate at U1B or U1A in oocytes, the other commonly used transcription start sites in brain. Our Southern blot results confirmed their use in the brain, but did not detect their utilization in oocytes. We did detect transcripts initiating at UIB in one pool of oocytessuggesting that there may be small discrepancies between individual oocytes or donors-but larger distinctions between brain and oocyte transcription are still evident.
During the course of this work, two human oocyte RNA-seq datasets became available in the Gene Expression Omnibus. Query of these two datasets confirms the main findings above. In oocytes, nearly all SNRPN transcripts initiate at the AS-SRO or at U6.5 in strong preference to exon 1 (Fig. 2) . Also, as found by RT-PCR, RNA-Seq did not detect use of the upstream somatic promoters U1A and U1B by oocytes (Fig. S1) .
Characterization of the Bovine SNRPN Locus. As the AS-SRO sequence is not conserved from humans to mice, we sought to identify another species in which to test its transcription initiation function. The National Center for Biotechnology Information BLAST tool does identify an 880-bp sequence located 40 kb upstream of the bovine SNRPN gene with 68% overall identity (Fig. S2) . Similar to the mouse, exon 1 of the bovine SNRPN gene is hypermethylated on the maternal allele, with methylation acquisition in the oocyte being related to oocyte size (24, 25) . To date, no bovine SNRPN upstream exons appear in the UCSC Genome Browser, and application of 5′ RACE to bovine oocyte or hypothalamus RNA identified 5′ ends only in the vicinity of body exon 1 (Fig. 3A) . However, GENSCAN (26) identified three potential exons near the conserved AS-SRO sequence of the bovine genome. RT-PCR using forward primers in these putative exons paired with a reverse primer in exon 3 on bovine oocyte and hypothalamus RNA is shown in Fig. 3B . As predicted by the 5′ RACE and in contrast to humans, bovine oocytes use exon 1 as a transcription start site. Transcripts from within the AS-SRO conserved sequence were not detected in either oocytes or hypothalamus. However, similar to human oocytes, bovine oocytes use a transcription start site located just downstream of the AS-SRO sequence. Performing RACE with primers in either exons B or C did not lead to the identification of additional upstream exons. Taken together, these data suggest that the conserved AS-SRO sequence functions as a promoter to generate oocytespecific transcripts that are necessary to establish the maternal imprint at the PWS-AS locus.
Discussion
Results obtained primarily in mice point to a multistep pathway by which parental imprints are reset between generations. Parent-of-origin information, in the form of DNA methylation at imprinting control regions, is first applied during gametic development. These germline differentially methylated regions DMRs (gDMRs) are retained despite a widespread demethylation of both parental genomes during early cleavage divisions. Although maintained during somatic development, differential methylation at gDMRs is erased during fetal germ-cell development, particularly as primordial germ cells complete their migration to the fetal gonad (27) . In female embryos, DMR methylation first appears shortly after birth in a DNMT3A-and DNMT3L-dependent process that is tied to oocyte growth (25, 28, 29) . How specific regions are selected for methylation in oocytes is poorly understood, but substantial recent work indicates the essential role of transcription in setting methylation imprints in the female germline. Many maternal gDMRs are intergenic sites overlying promoters for transcripts that, in turn, silence genes in cis (22) . Chotalia et al. (30) first demonstrated the necessity for transcription-transiting maternal DMRs in oocytes to effect imprinting at the GNAS locus. At this locus, truncation of oocyte transcripts before the gDMR prevents acquisition of the methylation imprint. At the murine PWS-AS locus, transcripts derived from several promoters located upstream of the PWS-IC first appear in perinatal oocytes. These transcripts are necessary for methylation and silencing of Snrpn on the maternal allele (20) .
The AS-SRO is defined as the smallest region of overlap common to deletions associated with AS-imprinting defects. U5 and U6, the exons encoded within the 880-bp AS-SRO, have both consensus splice acceptor and donor sequences, consistent with being spliced into transcripts that initiate upstream at U1B or U1A (17) . Here we have explored the transcriptional activity of the AS-SRO. We find that the AS-SRO is the primary transcription start site for SNRPN transcripts in human oocytes. These transcripts use the U5 or U6 splice donor sequences to splice into SNRPN body exon 2. We interpret these results to indicate that the major function of the AS-SRO in oocytes is to drive transcripts across the PWS-IC and thereby set the imprint. We infer that imprint-setting transcripts are reduced or absent from genomes lacking the AS-SRO, resulting in AS-imprinting defects.
The mouse lacks a conserved AS-SRO sequence. Instead, the mouse has nine highly repeated upstream promoters located over 530 kb (31) . Although all nine repeats are unlikely to be active promoters, it is clear that some are used in both oocytes and somatic cells (10, (18) (19) (20) 32) . Removal of the three proximal promoters leads to a weak partial imprinting defect, consistent with functional complementation by the remaining upstream promoters (33) . Conversely, BAC transgenes bearing only the three proximal promoters generate sufficient transcripts for efficient imprinting (20) . How many times the transcription apparatus must transit the PWS-IC to set the imprint is unknown. However, the partial imprinting defect seen upon deletion of the three proximal promoters points to an increased risk of an imprinting defect with declining numbers of transcripts, in turn suggesting that multiple transits of the PWS-IC are necessary for reliable imprint setting in the mouse. Curiously, a polymorphism located within the AS-SRO is associated with an increased risk of AS-imprinting defects but is also present in unaffected individuals (34) . Assuming that this polymorphism affects the frequency of transcript initiation, multiple transits of the PWS-SRO are also likely for reliable imprint setting in humans.
We examined the transcription initiation potential of AS-SRO-like sequences in the cow. Here the AS-SRO region also has transcription initiation activity, consistent with the conserved sequence harboring oocyte-specific promoter elements. Also similar to humans, bovine oocytes use a transcription start site just downstream of the 3′ border of the AS-SRO.
This work identifies SNRPN upstream exons that had not been previously documented in somatic tissues. The upstream exon U6.5 appears to be robustly used in oocytes and is located only 40 bp downstream of the AS-SRO. Several explanations are possible for its location outside of the AS-SRO. First, RACE may not accurately identify the 5′ ends of U6.5 initiation sites that could lie farther upstream within the AS-SRO. Alternatively, the AS-SRO may generate sufficient transcripts to set an imprint in the absence of U6.5. Finally, the downstream border of the AS-SRO is defined by a single case of an AS-imprinting defect, as all other deletions in the area likely impinge on U6.5 (5, 7) . Whether the absence of U6.5 contributed to the imprinting defect in these other cases is unknown.
Mosaicism is detected in about 30% of individuals diagnosed with AS-imprinting defects (35, 36) . These are presumably cases in which the imprint was lost postfertilization. Deletions impinging on the AS-SRO have been detected in about 15-20% of imprinting defect cases. This implies that in about half of individuals with AS-imprinting defects, transcripts from the AS-SRO were not generated or the imprint at the PWS-SRO was not set in response to transiting transcription.
How does transcription lead to DNA methylation in oocytes? Oocyte availability is a challenge to molecular studies, but Kelsey and Feil (37) have speculated that the act of transcription results in a constellation of chromatin modifications that are conducive to interaction of DNMT3A and DNMTL, whereas other transcribed regions might be protected from methylation by CXXCdomain proteins. The relative abundance of bovine oocytes compared with those of humans or even rodents may make this system especially useful in the molecular testing of these ideas.
Materials and Methods
Human oocytes were collected from consented women attempting conception through in vitro fertilization, as well as from oocyte donors, at the University of Florida Reproductive Medicine clinic. In general, patients underwent ovarian stimulation using standard long Lupron suppression or GnRH antagonist protocols. Oocyte retrieval was scheduled for 36 h after administration of an ovulation trigger. Oocytes used in this study were derived from those that failed to fertilize following conventional insemination or from immature oocytes not included for intracytoplasmic sperm injection. Oocytes were briefly rinsed in Hepes-buffered medium (Cooper Surgical) and snap-frozen at −80°C. Human oocyte donation was approved by the University of Florida Institutional Review Board, Project 356-2012.
Bovine cumulus-oocyte complexes were obtained as previously described (38) , using a scalpel to slice 2-to 10-mm follicles on the surface of ovaries obtained from a local abattoir. Cumulus cells were removed from the oocytes by vortexing in a solution of 1,400 units/mL hyaluronidase in synthetic oviduct fluid (39) buffered with 10 mM Hepes in a 2-mL microcentrifuge tube for 3-4 min at 38°C. The oocytes were then washed three times in Dulbecco's PBS containing 0.1% (wt/vol) polyvinylpyrollidone (DPBS/ PVP), placed in warm drops of 0.1% (wt/vol) protease from Streptomyces griseus for 5 min to remove zona pellucidae and attached debris, rinsed three times in DPBS/PVP, and snap-frozen in liquid nitrogen. Animal tissue collection methods were approved by the University of Florida Animal Use and Care Committee.
Oocyte RNA was isolated using the PicoPure RNA kit (Life Sciences catalog # KIT0204). Oocytes were harvested into extraction buffer provided by the kit, combined into groups of 6 (human) or 10 (cow), and processed into RNA following the manufacturer's guidelines. Human brain RNA was generously Most RACE products in hypothalamus and oocytes had 5′ ends at body exon 1. "H" and "O" refer to RACE products identified in the hypothalamus or oocyte, respectively. A new variably sized exon (white) located between body exons and 1 and 2 was found in several RACE products. This exon would be expected to disrupt expression of SNURF (45) . (B) Southern blot of RT-PCR products amplified with forward primers in putative exons suggested by GENSCAN and reverse primer in exon 3. The blot was probed with body exon 2.
provided by Stormy Chamberlain at the University of Connecticut. Bovine hypothalamus RNA was purified using the RNA-Bee reagent (Tel-Test, Inc.) following the manufacturer's instructions.
5′ RACE was performed using a RACE kit, version 2.0, as recommended by the manufacturer (Life Technologies). Brain and oocyte RNA was reverse transcribed into cDNA using a reverse primer in SNRPN exon 3 followed by purification and tailing with terminal deoxynucleotidyl transferase. The cDNA was amplified using a reverse primer in SNRPN exon 2 and a poly(C) tail-specific primer provided by the kit. Human transcripts could be further amplified using anchored tail primers provided by the manufacturer and the exon 2 reverse primer. Bovine transcripts could be further amplified using anchored tail primers provided by the manufacturer and a nested reverse primer exon 2-R2 or reverse primers located in regions upstream of SNRPN as mentioned. PCR amplifications were performed under the following conditions: 1 min at 94°, followed by 35 cycles of 30 sec at 94°, 30 sec at 55°, and 1 min at 72°. All RACE products were cloned using the TOPO TA kit (Life Technologies) and subjected to Sanger sequencing.
For RT-PCR, random primed cDNA was synthesized using SuperScript II reverse transcriptase (Life Technologies) and amplified by RT-PCR under normal conditions. Products were separated on a 1.4% (wt/vol) agarose gel, Southern blotted, and hybridized with either human or bovine SNRPN exon 2. All primers used in this study are listed in Table S1 .
RNA-Seq data were downloaded from the Gene Expression Omnibus (GEO) database in Short Read Archive (SRA) format. These SRA files were converted to fastq format using an SRA toolkit. Sequences were aligned to the human genome (hg19) using Tophat2 (40) , and alignments were merged from biological replicates (n = 3) within each study. To generate the UCSC Genome Browser tracks, a bedGraph file was generated from aligned bam files using bedtools (41) . Human oocyte data were obtained from GEO studies GSE36552 and GSE44183 (42, 43) . The human brain RNA-Seq track is described in Wang et al. (44) , available as a UCSC Genome Browser track.
